Medical Devices
Cardiac Monitoring Devices Market Size, 2024-2033
USD Billion
The figures are in the full report. Request a free sample ↗
Market overview
| Study Period | 2024 - 2033 |
|---|---|
| Historic Year | 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2033 |
| Market Size (Base Year) | USD 9.0 Billion |
| Market Size (Forecast Year) | USD 15.5 Billion |
| Growth Rate (CAGR) | 7.0 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Pages from the sample report. Figures are shown as XX here; the full report has them.
See the full sample: Request a free sample ↗
This report covers the cardiac monitoring devices market: devices and related services used to record and analyse the heart's electrical activity and function, including Holter monitors, event monitors and wearable patch monitors, implantable loop recorders, resting and stress electrocardiogram (ECG) devices and cardiac output monitoring devices, used in hospitals and clinics, ambulatory surgical centres and homes. The market is valued at manufacturers' and service providers' revenue.
Cardiac monitoring is used to diagnose arrhythmias such as atrial fibrillation, to investigate palpitations and fainting, and to monitor heart function during surgery and intensive care.
Ageing populations and the rising prevalence of atrial fibrillation, heart failure and other cardiovascular diseases increase the need for heart rhythm monitoring, as undetected atrial fibrillation is a major cause of strokes.
Wearable patch monitors that can be worn for up to two weeks, implantable loop recorders that monitor for years, artificial intelligence that analyses ECG data and remote monitoring services are making long-term monitoring easier and more accurate.
However, reimbursement rules and payment levels shape demand in the United States and other markets, hospitals face budget pressure, and consumer wearables such as smartwatches with ECG features compete for basic screening.
The global Cardiac Monitoring Devices market is mainly classified based on device type and end user. By device type, the market is segmented into Holter monitors, implantable loop recorders, electrocardiogram (ECG/EKG) devices, cardiac output monitoring devices, event monitors and other devices. By end user, it covers hospitals and clinics, ambulatory surgical centres, homecare settings and other end users.
ECG devices and Holter and patch-based ambulatory monitors account for the largest shares, with long-term wearable patches growing fastest. Implantable loop recorders are a high-value segment for long-term arrhythmia detection, and cardiac output monitoring devices are used mainly in surgery and intensive care.
Hospitals and clinics are the largest end users, while homecare settings are growing fastest as more monitoring is done remotely.
North America is the largest market, led by the United States, with high use of long-term ambulatory monitoring, implantable loop recorders and remote monitoring services supported by Medicare reimbursement.
Europe is the second-largest market with established ECG and Holter use. Asia-Pacific is expected to grow fastest as ageing populations and hospital investment in China, Japan and India increase cardiac monitoring, while South America and the Middle East and Africa are smaller markets.
Some of the major competitors in the global Cardiac Monitoring Devices market include iRhythm Technologies, Inc., Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V. (BioTel), GE HealthCare, Baxter (Hillrom), Nihon Kohden Corporation, Spacelabs Healthcare (OSI Systems), Schiller AG, Biotronik SE & Co. KG, Edwards Lifesciences, Masimo, and AliveCor.
The Cardiac Monitoring Devices market is moderately concentrated by segment. iRhythm and Philips lead in ambulatory and patch monitoring, Medtronic, Abbott and Boston Scientific in implantable loop recorders, GE HealthCare, Baxter, Nihon Kohden, Schiller and Spacelabs in ECG and patient monitoring, and Edwards Lifesciences in cardiac output monitoring.
Ans: The Cardiac Monitoring Devices market was valued at USD 9.0 billion in 2025 and is projected to reach USD 15.5 billion by 2033, at a CAGR of 7.0% during the forecast period.
Ans: Long-term wearable patch monitors, AI-based ECG analysis, implantable loop recorders, remote monitoring services and atrial fibrillation screening are major opportunities.
Ans: The rising number of older people with heart rhythm disorders, together with easier long-term and remote monitoring, is the main growth driver.
Ans: North America is expected to have the largest share, while Asia-Pacific is expected to grow fastest.
Ans: ECG devices and ambulatory monitors, including Holter and patch monitors, are expected to account for the largest share.
New Medicare rules for 2026 change how cardiac monitoring is paid in the United States, the largest market. Some monitoring codes now include value-based criteria, and supervision of monitoring can be provided virtually, which favours providers that can show measurable results and run efficient remote services.
Long-term continuous ECG monitoring with patch devices has grown quickly as reimbursement became clearer, and the leading patch provider reported strong growth and reached profitability in 2025.
The US government opened a national security investigation in 2025 into imports of medical equipment, devices and consumables, which could lead to tariffs on imported monitors and components.
This report assumes stable reimbursement with gradual shifts towards value-based payment and that tariff effects are manageable, and treats payment cuts and broad device tariffs as the main risks.
Backed by 1 million+ hours of research experience across the industries we cover.
Domains covered
Countries covered
Committed to timely delivery
Projects delivered